Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Vet Parasitol Reg Stud Reports ; 25: 100601, 2021 07.
Artículo en Inglés | MEDLINE | ID: mdl-34474794

RESUMEN

Toxoplasma gondii, the cause of toxoplasmosis is an obligate intracellular protozoan parasite of veterinary and public health importance. Ground feeding birds play an active role in the epidemiology of the disease and are the best indicators of soil contamination with the oocysts. Thirteen (14.1%; 95% CI = 7.7-23.0) of the 92 wild birds (6 of Coliformes; 4 of Columbiformes; 67 of Passeriformes and 15 of Piciformes) captured from Shere hills and 43 (9.3%; 95%CI = 4.9-12.4) of the 460 local chickens obtained across 3 senatorial regions of Plateau State, Nigeria were positive for anti-T. gondii antibodies using enzyme linked immunosorbent assay (ELISA). Varying prevalence (16.7-100%) of anti-T. gondii antibodies were recorded across 10 of 35 wild bird species; 2 (28.6) of 7 African thrush (Turdus pelios), 2 (33.3) of 6 speckled mouse bird (Colius striatus), 1 (20.0%) of 5 speckled fronted weaver (Sporopipes frontalis), 1 (33.3%) of 3 Northern Red bishop (Euplectes franciscanus), 1 (50.0%) of 2 village weaver (Ploceus cucullatus), 2 (28.6%) of 7 common bulbul (Pycnonotus barbatus), 1 (50.0%) of 2 black crowned tchagra (Tchagra senegalus), 1 (50.0%) of 2 black billed wood dove (Turtur abyssinicus), 1 (100.0%) of 1 mocking cliff chat (Thamnolaea cinamomeiventris), 1 (16.7) of 6 vieillot's barbet (Lybius vieilloti). The prevalence did not vary significantly based on the sex (p = 0.14), feeding guild (p = 0.53) and the taxonomic order (p = 0.62) of the wild birds. Regional based prevalence among local chickens ranged between 8.0 and 11.8% across the 3 senatorial zones. The source (p = 0.513; 95% CI = 4.9-16.8) and age (p = 0.797; 95% CI = 4.9-16.8) of local chickens were not associated with T. gondii seropositivity. Seropositivity was higher in the females (95% CI = 9.1-18.3) than in the males (p = 0.004; 95% CI = 3.0-9.4). This is the first report of the serological evidence of exposure to T. gondii infection in a wide variety of wild birds and local chickens in the area. It suggest that birds in this region are important asymptomatic intermediate hosts and play a role in the maintenance of the organism in the ecosystem.


Asunto(s)
Enfermedades de las Aves de Corral/epidemiología , Enfermedades de los Roedores , Toxoplasmosis Animal , Animales , Pollos , Ecosistema , Femenino , Masculino , Nigeria/epidemiología , Enfermedades de los Roedores/epidemiología , Estudios Seroepidemiológicos , Toxoplasma , Toxoplasmosis Animal/epidemiología , Toxoplasmosis Animal/parasitología
2.
Cent Eur Neurosurg ; 70(3): 109-14, 2009 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-19701868

RESUMEN

BACKGROUND AND STUDY AIMS: Melatonin is an important antioxidant agent with a protective role in the prevention of oxidative stress. We designed an experimental study which focused on the potential neuroprotective effect of melatonin on peripheral nerve injury. MATERIALS AND METHODS: Sciatic nerve injury was induced in the mid thigh region of 30 male Wistar rats by clip compression. Melantonin was injected intraperitoneally in 15 of the 30 rats. Electron microscope and biochemical studies were performed to assess the potential beneficial effect of melatonin on peripheral nerve regeneration. Changes to cellular organelles, myelin lamellae and axons were studied. RESULTS: There was a significant difference between the melatonin and nerve injury groups. Rats treated with melatonin demonstrated significant structural protection of the myelin lamellae compared to the nerve injury group. Axonal shrinkage and myelin changes were not prominent histopathologically in melatonin-treated group. Biochemical analysis confirmed the neuroprotective effects of melatonin with significantly lower lipid peroxidation and myeloperoxidase activity measurements in the melatonin-treated group compared to the neural injury group. The results indicate that melatonin can improve neural healing. CONCLUSION: With its neuroprotective effect, as demonstrated in this experimental peripheral nerve injury, melatonin might be used successfully in clinical practice. Further studies on the correct dosage and possible side effects are necessary.


Asunto(s)
Melatonina/farmacología , Fármacos Neuroprotectores , Traumatismos de los Nervios Periféricos , Nervios Periféricos/patología , Animales , Axones/metabolismo , Axones/ultraestructura , Inyecciones Intraperitoneales , Peroxidación de Lípido/efectos de los fármacos , Masculino , Malondialdehído/metabolismo , Microscopía Electrónica , Vaina de Mielina/metabolismo , Vaina de Mielina/ultraestructura , Orgánulos/efectos de los fármacos , Orgánulos/metabolismo , Orgánulos/ultraestructura , Nervios Periféricos/metabolismo , Peroxidasa/metabolismo , Ratas , Ratas Wistar , Nervio Ciático/lesiones , Nervio Ciático/metabolismo , Nervio Ciático/patología
3.
JAMA ; 283(6): 763-70, 2000 Feb 09.
Artículo en Inglés | MEDLINE | ID: mdl-10683055

RESUMEN

CONTEXT: Previous studies of testosterone supplementation in HIV-infected men failed to demonstrate improvement in muscle strength. The effects of resistance exercise combined with testosterone supplementation in HIV-infected men are unknown. OBJECTIVE: To determine the effects of testosterone replacement with and without resistance exercise on muscle strength and body composition in HIV-infected men with low testosterone levels and weight loss. DESIGN AND SETTING: Placebo-controlled, double-blind, randomized clinical trial conducted from September 1995 to July 1998 at a general clinical research center. PARTICIPANTS: Sixty-one HIV-infected men aged 18 to 50 years with serum testosterone levels of less than 12.1 nmol/L (349 ng/dL) and weight loss of 5% or more in the previous 6 months, 49 of whom completed the study. INTERVENTIONS: Participants were randomly assigned to 1 of 4 groups: placebo, no exercise (n = 14); testosterone enanthate (100 mg/wk intramuscularly), no exercise (n = 17); placebo and exercise (n = 15); or testosterone and exercise (n = 15). Treatment duration was 16 weeks. MAIN OUTCOME MEASURES: Changes in muscle strength, body weight, thigh muscle volume, and lean body mass compared among the 4 treatment groups. RESULTS: Body weight increased significantly by 2.6 kg (P<.001) in men receiving testosterone alone and by 2.2 kg (P = .02) in men who exercised alone but did not change in men receiving placebo alone (-0.5 kg; P = .55) or testosterone and exercise (0.7 kg; P = .08). Men treated with testosterone alone, exercise alone, or both experienced significant increases in maximum voluntary muscle strength in leg press (range, 22%-30%), leg curls (range, 18%-36%), bench press (range, 19%-33%), and latissimus pulls (range, 17%-33%). Gains in strength in all exercise categories were greater in men assigned to the testosterone-exercise group or to the exercise-alone group than in those assigned to the placebo-alone group. There was a greater increase in thigh muscle volume in men receiving testosterone alone (mean change, 40 cm3; P<.001 vs zero change) or exercise alone (62 cm3; P = .003) than in men receiving placebo alone (5 cm3; P = .70). Average lean body mass increased by 2.3 kg (P = .004) and 2.6 kg (P<.001), respectively, in men who received testosterone alone or testosterone and exercise but did not change in men receiving placebo alone (0.9 kg; P = .21). Hemoglobin levels increased in men receiving testosterone but not in those receiving placebo. CONCLUSION: Our data suggest that testosterone and resistance exercise promote gains in body weight, muscle mass, muscle strength, and lean body mass in HIV-infected men with weight loss and low testosterone levels. Testosterone and exercise together did not produce greater gains than either intervention alone.


Asunto(s)
Ejercicio Físico/fisiología , Infecciones por VIH/fisiopatología , Músculo Esquelético/fisiología , Testosterona/metabolismo , Testosterona/farmacología , Pérdida de Peso/fisiología , Adulto , Composición Corporal , Método Doble Ciego , Infecciones por VIH/metabolismo , Humanos , Masculino , Persona de Mediana Edad , Perfil de Impacto de Enfermedad , Testosterona/administración & dosificación , Muslo
4.
Rev Elev Med Vet Pays Trop ; 44(3): 283-6, 1991.
Artículo en Inglés | MEDLINE | ID: mdl-1842225

RESUMEN

Blood smears of 202 turkeys (94 males and 108 females) in the Nsukka area (Nigeria) were examined for malaria parasites. Among the turkeys examined 44.1% (95% confidence interval, 0.441 +/- 0.069) were infected with Plasmodium spp., 46.8% males and 41.7% females. A total of 175 adults and 27 growing turkeys (aged 6-16 weeks) were examined and 45.7 and 33.3%, respectively were infected. Twenty out of 60 reared turkeys under intensive management systems and 65 of 142 turkeys managed semi-intensively were infected. The mean PCV value for the infected turkeys was 29.95 +/- 3.36% and significantly different (P less than 0.01) from the mean PCV value of 37.3 +/- 3.7 obtained from the uninfected turkeys. Eleven out of the 89 positive cases were clinical cases. Four critically sick turkeys died one day after treatment. Chloroquine phosphate at 5 mg/kg body weight administered i.m daily for 3 days or 250 mg tablets given orally for 5 days as well as a parenteral administration of pyrimethamine (0.3 mg/kg body weight) for 2 days were effective in the treatment of the infection.


Asunto(s)
Malaria Aviar/epidemiología , Enfermedades de las Aves de Corral/epidemiología , Pavos , Animales , Femenino , Masculino , Nigeria/epidemiología , Prevalencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...